Product Description
To address complex cutaneous conditions—from allergies and infections to immune-mediated disorders—we develop precision-targeted therapies (pet-specific monoclonal antibodies and JAK/IL-31 inhibitors) for atopic dermatitis, intelligent topical formulations (quick-drying, anti-lick film-forming sprays and gels) to enhance local bioavailability, and topical probiotic preparations for skin microflora restoration. By integrating targeted delivery, transdermal technologies, and optimized formulations, we maximize therapeutic outcomes while minimizing systemic adverse effects.
